Terumo
Terumo Corporation, a leading global medical technology company headquartered in Japan, has been at the forefront of healthcare innovation since its founding in 1921. With a strong presence in regions such as Europe, Asia, and the Americas, Terumo operates primarily within the medical devices industry, focusing on areas like vascular intervention, blood management, and surgical products. Renowned for its commitment to quality and safety, Terumo offers a diverse range of core products, including advanced catheter systems, blood collection devices, and infusion systems. These products are distinguished by their cutting-edge technology and user-centric design, ensuring optimal performance in clinical settings. As a trusted partner in healthcare, Terumo has achieved significant milestones, including numerous certifications and recognitions for excellence in medical technology, solidifying its position as a key player in the global market.
DitchCarbon Score
How does Terumo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Terumo's score of 56 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Terumo's reported carbon emissions
In 2023, Terumo Corporation reported total carbon emissions of approximately 206,031,000 kg CO2e globally, with specific emissions from Japan amounting to about 92,643,000 kg CO2e. The company's emissions are categorised into Scope 1, Scope 2, and Scope 3, with the latest data indicating significant contributions from all three scopes. Notably, Scope 1 emissions were about 64,123,000 kg CO2e, while Scope 2 emissions reached approximately 141,908,000 kg CO2e. Terumo has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by 2030, using 2018 as the baseline year. Additionally, the company targets a 60% reduction in Scope 3 emissions per unit of revenue over the same timeframe. Furthermore, Terumo UK has committed to achieving net zero emissions by 2050, reflecting a long-term dedication to sustainability. These initiatives align with industry standards for climate action, demonstrating Terumo's proactive approach to mitigating its environmental impact and contributing to global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 00,000,000 | - | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Terumo is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
